J Virol, April 1998, p. 2846-2854, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Heinrich-Pette-Institut,
Received 15 September 1997/Accepted 19 December 1997
Retroviruses are produced as immature particles containing
structural polyproteins, which are subsequently cleaved by the viral
proteinase (PR). Extracellular maturation leads to condensation of the
spherical core to a capsid shell formed by the capsid (CA) protein,
which encases the genomic RNA complexed with nucleocapsid (NC)
proteins. CA and NC are separated by a short spacer peptide (spacer
peptide 1 [SP1]) on the human immunodeficiency virus type 1 (HIV-1)
Gag polyprotein and released by sequential PR-mediated cleavages. To
assess the role of individual cleavages in maturation, we constructed
point mutations abolishing cleavage at these sites, either alone or in
combination. When all three sites between CA and NC were mutated,
immature particles containing stable CA-NC were observed, with no
apparent effect on other cleavages. Delayed maturation with irregular
morphology of the ribonucleoprotein core was observed when cleavage of
SP1 from NC was prevented. Blocking the release of SP1 from CA, on the
other hand, yielded normal condensation of the ribonucleoprotein core
but prevented capsid condensation. A thin, electron-dense layer near
the viral membrane was observed in this case, and mutant capsids were
significantly less stable against detergent treatment than wild-type
HIV-1. We suggest that HIV maturation is a sequential process
controlled by the rate of cleavage at individual sites. Initial rapid
cleavage at the C terminus of SP1 releases the RNA-binding NC protein
and leads to condensation of the ribonucleoprotein core. Subsequently, CA is separated from the membrane by cleavage between the matrix protein and CA, and late release of SP1 from CA is required for capsid
condensation.
*
Corresponding author. Mailing address:
Heinrich-Pette-Institut, Martinistr. 52, D-20251 Hamburg, Germany.
Phone: 49 40 48051-241. Fax: 49 40 48051-184. E-mail:
hgk{at}hpi.uni-hamburg.de.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|